Search Results 441-450 of 1460 for 牛客网的ai面试,ai少女官网下载,法律ai网站,在线ai绘画网站,ai语音合成网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. A Study of the Safety and Effectiveness of NEOD001 for Treating Previously Treated Patients with Persistent Cardiac Dysfunction Related to Light Chain Amyloidosis - Mayo Clinic

   About this study. The purpose of this study is to assess the effectiveness and safety of NEOD001 administered intravenously in adults with light chain ...

2. Linda N. Dao, M.D. - Doctors and Medical Staff - Mayo Clinic

   The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology. 5X My Gift!

3. An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis - Mayo Clinic

   The purpose of this study is to provide additional treatment with NEOD001 and evaluate long term safety and tolerability for patients wih light chain ...

4. Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy - Mayo Clinic

   The main purpose of the study is to test if taking a study drug called emricasan (also known as IDN-6556 and PF-03491390) will affect overall patient survival ...

5. Library scale lentiviral production - Genetic Screening and Engineering Core - Mayo Clinic Research Core Facilities

   Mayo Clinic's Genetic Screening and Engineering Core provides scalable lentiviral production for CRISPR libraries that are commercially available and ...

6. A Study to Assess Symptoms in Working Age Stroke Survivors - Mayo Clinic

   The purposes of this study are to investigate the level of correspondence between the most severe and most bothersome symptoms, and to examine discordant ...

7. Mooney Mori, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Mooney Mori, M.D., Ph.D., is a physician-scientist at Mayo Clinic specializing in organ generative medicine and end-stage lung disease treatments.

8. Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

   The purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of ...

10. Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

    About this study. The Valchlor PROVe study is a multi-center, prospective, observational, US-based drug study that longitudinally follows patients with ...